Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.37
24.11.21
€6.00
24.11.22
-24.21%
15.02.22

Could be worthwhile Investment >10% per year
melinda 
24.11.21 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.51
01.02.22
€4.15
01.02.23
-7.69%
10.02.22

Could be worthwhile Investment >10% per year
melinda 
01.02.22 50%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.66
02.02.22
-
02.02.23
-3.83%
06.02.22

Risky Investment
Wolf_of_WS 
02.02.22 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.04
02.02.22
-
02.02.23
-4.33%
06.02.22

Risky Investment
Wolf_of_WS 
02.02.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.52
23.01.22
-
23.01.23
7.06%
06.02.22

Could be worthwhile Investment >10% per year
bundfuture 
23.01.22 50%
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.76
23.01.22
-
23.01.23
-8.12%
06.02.22

Risky Investment
bundfuture 
23.01.22 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€74.55
23.01.22
-
23.01.23
7.12%
06.02.22

Could be very worthwhile Investment >20% year
quelbe60 
23.01.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
quelbe60 
23.01.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
23.01.22
-
23.01.23
15.82%
06.02.22

Risky Investment
quelbe60 
23.01.22 50%
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
me8 
27.01.22 0%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
melinda 
10.01.22 0%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.41
20.12.21
€7.20
20.12.22
-15.91%
30.01.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
20.12.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€125.18
28.05.21
€200.00
28.05.22
-35.69%
29.01.22

Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies
jomobb 
28.05.21 80%
buy
Supernus Pharmaceuticals

Start price
Target price
Perf. (%)
€25.20
25.01.21
€28.00
25.01.22
3.97%
26.01.22

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€31.33
23.01.21
-
23.01.22
-55.15%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 0%
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
23.01.21
€88.00
23.01.22
-30.36%
24.01.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
kostojunior 
23.01.21 80%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
23.01.21
€3.00
23.01.22
-38.46%
24.01.22

Could be very worthwhile Investment >20% year
Higher risks for its business
yester 
23.01.21 0%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.02
09.01.22
-
09.01.23
-18.54%
23.01.22

Could be very worthwhile Investment >20% year
blaugold 
09.01.22 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.69
13.01.22
-
13.01.23
-12.15%
23.01.22

Could be very worthwhile Investment >20% year
blaugold 
13.01.22 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€3.71
09.01.22
-
09.01.23
-11.02%
22.01.22

Could be worthwhile Investment >10% per year
bundfuture 
09.01.22 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€12.17
13.01.22
-
13.01.23
-7.52%
22.01.22

Could be worthwhile Investment >10% per year
Vassago1 
13.01.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.62
14.01.22
-
14.01.23
-12.67%
22.01.22

Could be worthwhile Investment >10% per year
Vassago1 
14.01.22 50%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€24.44
14.01.22
-
14.01.23
-10.19%
22.01.22

Risky Investment
Vassago1 
14.01.22 50%
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
nvestor 
08.01.22 50%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
15.01.21 0%